Diagnosis usually begins with clinical evaluation and family history. Blood tests may reveal elevated CK levels, suggesting muscle damage. Genetic testing, including DNA sequencing and Multiplex Ligation-dependent Probe Amplification (MLPA), can confirm the presence of mutations in the dystrophin gene. Prenatal testing and carrier screening are also available for families with a known history of dystrophinopathies.
